Lineage Cell Therapeutics, Inc. (LCTX)
0.7838
-0.04
(-4.41%)
USD |
NYAM |
Nov 20, 16:00
0.8197
+0.04
(+4.58%)
After-Hours: 19:06
Lineage Cell Therapeutics Gross Profit (TTM) : 10.00M for Sept. 30, 2026
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| September 30, 2026 | 10.00M |
| June 30, 2026 | 12.27M |
| March 31, 2026 | 13.95M |
| December 31, 2025 | 13.71M |
| September 30, 2025 | 9.918M |
| June 30, 2025 | 10.02M |
| March 31, 2025 | 8.687M |
| December 31, 2024 | 8.556M |
| September 30, 2024 | 7.65M |
| June 30, 2024 | 4.951M |
| March 31, 2024 | 6.657M |
| December 31, 2023 | 7.582M |
| September 30, 2023 | 7.55M |
| June 30, 2023 | 9.234M |
| March 31, 2023 | 10.47M |
| December 31, 2022 | 13.25M |
| September 30, 2022 | 12.19M |
| June 30, 2022 | 10.63M |
| March 31, 2022 | 6.585M |
| December 31, 2021 | 1.601M |
| September 30, 2021 | 0.747M |
| June 30, 2021 | -0.48M |
| March 31, 2021 | -1.118M |
| December 31, 2020 | -1.651M |
| September 30, 2020 | -1.492M |
| Date | Value |
|---|---|
| June 30, 2020 | -1.933M |
| March 31, 2020 | -1.989M |
| December 31, 2019 | -1.994M |
| September 30, 2019 | -2.494M |
| June 30, 2019 | -1.751M |
| March 31, 2019 | 0.387M |
| December 31, 2018 | 0.759M |
| September 30, 2018 | 1.469M |
| June 30, 2018 | 2.181M |
| March 31, 2018 | 0.19M |
| December 31, 2017 | -0.024M |
| September 30, 2017 | 0.168M |
| June 30, 2017 | -0.087M |
| March 31, 2017 | 0.216M |
| December 31, 2016 | 0.806M |
| September 30, 2016 | 0.224M |
| June 30, 2016 | -0.03M |
| March 31, 2016 | 0.2817M |
| December 31, 2015 | -0.3997M |
| September 30, 2015 | -1.942M |
| June 30, 2015 | -2.918M |
| March 31, 2015 | -3.882M |
| December 31, 2014 | -3.995M |
| September 30, 2014 | -2.083M |
| June 30, 2014 | -1.705M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Curis, Inc. | 1.076M |
| Armata Pharmaceuticals, Inc. | 5.517M |
| Voyager Therapeutics, Inc. | 21.38M |
| Black Diamond Therapeutics, Inc. | -0.149M |
| Invivyd, Inc. | 53.96M |